Feedback / Questions
Adze-1.17-CD40L - Adze Biotech
https://www.einnews.com/pr_news/615545344/adze-biotechnology-announces-orphan-drug-designation-granted-to-adze-1-17-cd40l-for-the-treatment-of-malignant-glioma
Feb 7, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next